Analysis of hepatitis C virus decline during treatment with the protease inhibitor danoprevir using a multiscale model.
The current paradigm for studying hepatitis C virus (HCV) dynamics in patients utilizes a standard viral dynamic model that keeps track of uninfected (target) cells, infected cells, and virus. The model does not account for the dynamics of intracellular viral replication, which is the major target o...
Main Authors: | Libin Rong, Jeremie Guedj, Harel Dahari, Daniel J Coffield, Micha Levi, Patrick Smith, Alan S Perelson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS Computational Biology |
Online Access: | http://europepmc.org/articles/PMC3597560?pdf=render |
Similar Items
-
Danoprevir for the Treatment of Hepatitis C Virus Infection: Design, Development, and Place in Therapy
by: Miao M, et al.
Published: (2020-07-01) -
A New Age-Structured Multiscale Model of the Hepatitis C Virus Life-Cycle During Infection and Therapy With Direct-Acting Antiviral Agents
by: Barbara de M. Quintela, et al.
Published: (2018-04-01) -
Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.
by: Libin Rong, et al.
Published: (2009-10-01) -
Protease inhibitors for the treatment of hepatitis C virus infection
by: de Leuw, Philipp, et al.
Published: (2017-11-01) -
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection
by: Gentile I, et al.
Published: (2014-06-01)